Can we implant valved mitral prosthesis within all kinds of mitral rings through a transapical approach?  by Tavlasoglu, Murat & Arslan, Zekeriya
Letters to the Editorand reversed saphenous vein grafts to
the right and circumflex coronary ar-
teries. The right, left anterior descend-
ing, and left circumflex coronary
arteries were grafted in that order
with proximal first technique for the
reversed saphenous vein grafts. This
actually led to immediate improve-
ment of the right ventricular ejection
fraction, as confirmed on echocardi-
ography. Then with the finger-dip
technique we passed a 16-gauge
needle through a pledgeted purse-
string 4-0 polypropylene (Prolene) su-
ture on the right ventricular anterior
wall to insert a guide wire across the
septal tear into the left ventricle. The
20-mm Amplatzer septal occluder
device was then deployed through
a 9F vascular sheath entirely into the
necrotic cavity in the septum. The de-
vice deployment did not appear satis-
factory initially because of the nature
of the large septal necrotic cavity. It
soon became clear, however, that the
device had entrenched itself nicely,
was well trapped in the septal aneu-
rysm, and had nearly completely
obliterated the large 3:1 shunt. In
2008, we had a 13-month follow-up
with stable device intracardiac and
septal position with New York Heart
Association class I functional status.
Unlike Love and colleagues,1 we
deployed the device totally intracar-
diac and were able to discharge the
patient on the 9th postoperative day.
The patient exhibited no evidence of
subsequent myocardial failure and
continued to show improved contrac-
tile function despite a continued small
residual ventricular septal defect. We
believe that placing a large disk on
the exterior anterior right ventricular
surface may contribute to late myocar-
dial failure because of fibrosis on a de-
vice primarily meant for intravascular
placement. This kind of technique
would also be limited in application
if a right ventricular infarction is
present, as in our case, because of
the risk of erosion into the infarcted
myocardium.1536 The Journal of Thoracic andHarshbir Singh Pannu,
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j.jtcvs.2012.05.083CAN WE IMPLANT VALVED
MITRAL PROSTHESIS WITHIN
ALL KINDS OF MITRAL RINGS
THROUGH ATRANSAPICAL
APPROACH?
To the Editor:
We appreciate the admirable efforts
of Holzhey and colleagues1 to treat
a patient who had double valve dis-
ease and coronary heart disease with
poor left ventricular function. The pa-
tient had undergone mitral valve re-
construction and coronary artery
bypass grafting 12 years previously
and was in New York Heart Associa-
tion functional class IV. The echocar-
diographic examination revealed
structural degeneration of the repaired
mitral valve, with moderate to severe
mitral stenosis and grade II insuffi-
ciency. Further echocardiographic
findings included severely stenosed
aortic valve disease and moderate tri-
cuspid insufficiency. Moreover, 2 de
novo lesions of the proximal right
coronary artery were detected by
coronary angiography. SummarizingCardiovascular Surgery c December 20briefly, it was a complex case for inter-
vention. Nonetheless the patient was
treated successfully.
Anson and associates2 performed
transcatheter mitral valve-in-valve
implantation in circular-shaped pros-
thesis in 11 patients. They concluded
that proper anchoring of the balloon-
expandable valve within the sewing
ring of the mitral prosthesis ensured
stability and minimized paravalvular
leakage. We think that some points
about the procedure performed in the
mitral position have to be clarified to
avoid misunderstanding.
First, what kind of ring had been
implanted in previous surgery: rigid,
semirigid, or flexible? We know that
some of the flexible rings, which are
easily deformable, have polyester
cores. The Carpentier-Edwards clas-
sic ring (Edwards Lifesciences Corp,
Irvine, Calif), which is hardly deform-
able, has a titanium core, and
Carpentier-McCarthy-Adams IMR
ETlogix ring (Edwards Lifesciences),
which is nondeformable, also has
a rigid titanium core.3 The structures
of the rings are important even if the
patient hasn’t undergone coronary ar-
tery bypass grafting. If the ring has
rigid structure such as a titanium
core, balloon valvuloplasty or balloon
inflation to expand the valved prosthe-
sis may not result in circular mitral
ring. This may lead to paracommisu-
ral leaks between the prosthesis and
the ring. Holzhey and colleagues1
claim that there were 2 trivial jets be-
tween the prosthesis and the ring. Was
the previously implanted ring flexi-
ble? Another point to be clarified is
the balloon pressure during balloon
valvuloplasty or expansion of a valved
prosthesis in the mitral position. In
such cases, how much is the pressure
that we can apply to make the ring in
circular shape?
In conclusion, this is an appreciable
study. We as readers thank Holzhey
and colleagues1 for sharing their
knowledge and experience about
such a complicated case.12
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j.jtcvs.2012.05.084IS THE CAUSE OF DEATH
IN HYPERTROPHIC
CARDIOMYOPATHY LOW
PRESSURE GRADIENT IN LEFT
VENTRICULAR OUTFLOW?
To the Editor:
We congratulate Schaff and col-
leagues1 on their recent study. We
wish, however, to emphasize some
points that we believe they should
have taken into consideration.
We could not figure out how to
correlate the preoperatively used drug
with the survival rate (see original
Table 21). To agree with the results,
one should standardize the last echo-
cardiographic data of the lost patients
with those of the living patients. We
think that preoperative echocardio-
graphic status of the patient could not
be correlated with the survival of the
6th postoperative year. We could not
clearly understand whether it was pos-
tulated that thewall thickness of 22mm
(see original Figure 41) did not have an
impact on survival or whether one
would bring the survival to an expected
level with the use of drugs? We thinkThe Journalthat the original Figure 2 is in contra-
diction with the original Figure 4.1
Ommen and associates2 previ-
ously stated that the pressure gradi-
ent does not have an impact on
(cardiac) survival because their mor-
tality was also 6% in the nonob-
structive group. Nevertheless, there
was limited information because of
the lack of postoperative echocar-
diographic data in the myectomy
group with respect to postoperative
pressure gradient, wall thickness,
and left ventricular diameters.
The standardization of the groups
after inclusion of the final echocardio-
graphic data of the lost patients would
yield the definitive results of this
study.
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TREATMENT FOR INFECTIVE
ENDOCARDITIS: DOES IT
COME AT THE EXPENSE OF
WORSE NEUROLOGIC
OUTCOMES?
To the Editor:
With much interest we read the
recent article of Funakoshi and col-
leagues,1 suggesting superior long-
term outcomes for patients with
infective endocarditis after early sur-
gical treatment relative to a purported
conventional treatment strategy.of Thoracic and Cardiovascular SurgerAlthough the results seem in line
with general consensus, several meth-
odologic issues arise, affecting the
validity of the study’s conclusions.
First, we would like to comment on
the definition of the study groups. The
conventional treatment group includes
patientswho have been treatedwith an-
tibiotics only, as well as patients who
have been operated on at a later stage.
In our opinion, these patients should
not be combined into a single treatment
group. To illustrate this, the in-hospital
mortality is 5% for both the early and
late surgical groups. On the other
hand, the mortality of the conventional
treatment group seems higher (5% vs
13%; P¼ .08), possibly caused by un-
favorable results in the nonsurgical
group. It would have been more infor-
mative to have 3 groups for compari-
son: patients after early surgical
treatment, patients after late surgical
treatment, and patients who have
been treated with antibiotics only.
Correspondingly, it is problematic to
interpret the result of the propensity-
matched comparison, because it re-
mains unclear how many patients in
the conventional treatment group have
undergone surgical treatment. To as-
sess the role of early surgical treatment
in infective endocarditis adequately, it
would be more instructive to compare
the results of early surgical treatment
with those of late surgical treatment.
Second, the chosen period of
14 days after the initial diagnosis as
cutoff point for early versus late
surgery seems questionable. Several
studies show that the risk of embolic
events dramatically drops as early as
1 week of antibiotic treatment.2 Ac-
cordingly, the European guidelines3
on this specific subject advise that
early surgical treatment should be per-
formed within several days after the
diagnosis, instead of after 14 days,
whenever there is an indication for
early operation.
Another point of concern is the
postoperative neurologic outcome.
Among patients who had complicat-
ing stroke on admission, 30% hady c Volume 144, Number 6 1537
